Such a frustrating hold.
NG Biotech Pregnancy Test using AT1 technology rejected by the TGA. Not great! Also their US based interest has clearly gone by the wayside.
Just when you think their WHO and HIV sales are starting to gain momentum they release a quarterly showing anaemic sales.
You would think they are close to getting a decent contract from FebriDx orders, but that is a few quarters away until we hit US flu season.
Ann: Quarterly Activities Report and Appendix 4C, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
